|
2025
|
G/S
|
Medicated and pharmaceutical preparations for use in connection with humans, namely, antibiotics,... |
|
|
G/S
|
Providing a website featuring information on managing behavioral symptoms associated with Alzheim... |
|
|
G/S
|
Management of pharmacy benefit programs featuring a medical benefit co-pay card; Financial admini... |
|
|
G/S
|
Medicated and pharmaceutical preparations for the treatment and prevention of migraines; medicate... |
|
|
G/S
|
Prescription medicated and pharmaceutical preparations for the treatment and prevention of migrai... |
|
|
Invention
|
Pharmaceutical compositions comprising meloxicam.
Disclosed herein are compositions comprising a... |
|
|
Invention
|
Pharmaceutical compositions comprising bupropion and cysteine.
This disclosure relates to pharma... |
|
|
G/S
|
Medicated and pharmaceutical preparations for use in connection with humans, namely, those for th... |
|
|
G/S
|
Promoting public awareness of migraines; providing business management of pharmacy benefit progra... |
|
|
Invention
|
Pharmaceutical compositions comprising meloxicam. maxmax of meloxicam of 3 hours or less. |
|
|
Invention
|
Use of reboxetine to treat narcolepsy. Polymorph forms of reboxetine, and their therapeutic uses,... |
|
|
Invention
|
Compounds and combinations thereof for treating neurological and psychiatric conditions.
Describ... |
|
|
G/S
|
Medicated and pharmaceutical preparations for the treatment and prevention of migraines; Medicate... |
|
|
Invention
|
Phenylalkylamino carbamates for use in the treatment of attention deficit/hyperactivity disorder.... |
|
|
Invention
|
Use of esreboxetine to treat nervous system disorders. Described herein are methods of treating f... |
|
|
Invention
|
Use of reboxetine to treat narcolepsy. Described herein are methods of treating narcolepsy with c... |
|
2024
|
Invention
|
Microparticles containing bupropion.
This disclosure relates to microparticles containing buprop... |
|
|
Invention
|
Compounds and combinations thereof for treating depression in patients. This disclosure relates t... |
|
|
Invention
|
Pharmaceutical compositions comprising meloxicam.
Disclosed herein is a method of treating migra... |
|
|
Invention
|
Pharmaceutical compositions comprising bupropion and cysteine. This disclosure relates to pharmac... |
|
|
Invention
|
Pharmaceutical compositions comprising meloxicam. max of meloxicam of 3 hours or less. |
|
|
Invention
|
Solriamfetol for improving cognitive health in apnea patients. Disclosed herein are methods of im... |
|
|
Invention
|
Pharmaceutical compositions comprising meloxicam. Disclosed herein is a method of treating migrai... |
|
|
Invention
|
Use of reboxetine to treat narcolepsy.
Described herein are methods of treating narcolepsy with ... |
|
|
Invention
|
Dosage forms and methods for enantiomerically enriched or pure bupropion.
This disclosure relate... |
|
|
Invention
|
Use of solriamfetol for the treatment of orphan diseases. The present invention relates to a meth... |
|
|
G/S
|
Medicated and pharmaceutical preparations for use in
connection with humans, namely, antibiotics... |
|
|
Invention
|
Methods of administering solriamfetol to lactating women. Provided herein according to some embod... |
|
|
Invention
|
Solriamfetol for the treatment of certain neurological conditions. Disclosed herein are methods o... |
|
|
Invention
|
Solriamfetol for treating cognitive impairment in a subject with impaired cognition associated wi... |
|
|
Invention
|
Pharmaceutical compositions comprising a tolfenamic acid. max of meloxicam of 3 hours or less. |
|
|
G/S
|
Downloadable cloud-based software for the purpose of tracking, managing and storing information r... |
|
|
G/S
|
Downloadable cloud-based software for the purpose of
tracking, managing and storing information ... |
|
|
G/S
|
Promoting public awareness of migraines Medicated and pharmaceutical preparations for use in conn... |
|
|
G/S
|
Printed educational materials in the field of migraines Promoting public awareness of migraines P... |
|
|
Invention
|
Compositions for delivery of reboxetine.
Described herein are methods for the administration of ... |
|
|
Invention
|
Combination dosage forms and administration thereof.
This disclosure relates to methods of admin... |
|
|
G/S
|
Prescription medicines for the treatment of Fibromyalgia. |
|
|
G/S
|
Prescription medicines for the treatment of Fibromyalgia. |
|
2023
|
Invention
|
Use of mazindol to treat nervous system disorders. Described herein are methods of treating narco... |
|
|
G/S
|
Prescription medicines for the treatment of Fibromyalgia |
|
|
G/S
|
house mark for medicated and pharmaceutical preparations for use in connection with humans, namel... |
|
|
G/S
|
Management of pharmacy benefit programs featuring a medical benefit co-pay card; financial admini... |
|
|
G/S
|
Management of pharmacy benefit programs featuring a medical
benefit co-pay card (term considered... |
|
|
Invention
|
Methods of modulating tetrabenazine metabolites plasma levels using bupropion.
This disclosure r... |
|
2022
|
Invention
|
Methods and compisitions for ameliorating biomarkers associated with cardiovascualr risk using (r... |
|
2021
|
G/S
|
Prescription medicines for the treatment of migraines. |
|
|
G/S
|
Prescription medicines for the treatment of migraines. |
|
|
G/S
|
Consulting services in the field of health, namely pharmaceutical consultancy services; providing... |
|
|
G/S
|
Education services, namely, providing classes, seminars,
conferences and workshops in the field ... |
|
|
G/S
|
Providing an on-line forum for patients and doctors to communicate and discuss depression and tre... |
|
|
G/S
|
Providing an on-line forum for patients and doctors to
communicate and discuss depression and tr... |
|
|
G/S
|
Pharmaceutical preparations, namely, prescription medicines for the treatment of depression. |
